An underground market for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.
Investigational Treatment Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also obtaining discount codes.
Active Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and assertions of rapid British shipping. Vendors market the drug there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Concerns
However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could lead to users injecting substances of unknown origin.
Some professionals stated the popularity for the experimental drug could be linked to the rising price of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.
Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, risking penalties, legal action or imprisonment.
Service Response and Content Removal
Based on TikTok, the platform has removed problematic material and banned related keywords and search suggestions. The company stated it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Investigations also found groups with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of members, filled with images of weight loss, positive testimonials and detailed guides for mixing or injecting at home.
Within moments of entering one group, a seller shared contact information, where the majority of purchases take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.
Item Information and Pricing
Within these communities, messages display black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20mg. When asked how long a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for Telegram said it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are highly risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.
Her team has previously encountered patients injured by self-injection from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose users to possibly serious health risks”.
